Personal View: Low-dose Lung Radiotherapy for COVID-19 Pneumonia – The Atypical Science and the Unknown Collateral Consequence
Authors:
- 11 June 2020
- journal article
- editorial
- Published by Elsevier in Clinical Oncology
- Vol. 32 (8) , 497-500
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapyRadiotherapy and Oncology, 2019
- The "baby lung" became an adultIntensive Care Medicine, 2016
- Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelinesBritish Journal of Radiology, 2015
- How radiotherapy was historically used to treat pneumonia: could it be useful today?2013
- Is Disseminated Intravascular Coagulation the Major Cause of Mortality from Radiation at Relatively Low Whole Body Doses?Radiation Research, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- The effects of proton radiation on the prothrombin and partial thromboplastin times of irradiated ferretsInternational Journal of Radiation Biology, 2012